B
BVS
Bioventus Inc.
9.06
-0.04-0.44%After Hours: 9.06 0.00 0.00%16:10 04/10 EDT
OPEN/PREV CLOSE9.07/9.10
TODAY RANGE8.94-9.09
VOL326.72K
MARKET CAP753.38M
52 WEEK RANGE5.81-9.53
AVG VOL (3M)351.90K
% TURNOVER0.39%
TURNOVER--
P/E (TTM)27.46
% RANGE1.65%
EPS(TTM)0.3299
P/E(FORWARD)23.23
P/B3.390
BVPS2.673
DIVIDEND--
P/S1.099
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP537.75M
SHARES OUTSTANDING83.15M
NEXT EARNINGS05/04-05/08
FREE FLOAT59.35M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/27 13:00
Bioventus initiated with an Outperform at CJS Securities
TipRanks·03/14 02:04
Bioventus Director’s Surprise Stock Move Shakes Up Investor Buzz
Reuters·03/13 21:27
Bioventus Director Michelle McMurry-Heath Disposes of Common Shares
TipRanks·03/10 00:11
Bioventus Earnings Call Signals Profitable Growth Ahead
TipRanks·03/09 18:55
Bioventus management to meet with Barrington
Dow Jones·03/06 18:56
Bioventus Is Maintained at Outperform by Barrington Research
Dow Jones·03/06 18:56
Bioventus Price Target Raised to $14.00/Share From $13.00 by Barrington Research
Dow Jones·03/06 18:13
Bioventus Is Maintained at Buy by Craig-Hallum
Benzinga·03/06 18:03
Craig-Hallum Maintains Buy on Bioventus, Raises Price Target to $16
TipRanks·03/06 14:05
Bioventus price target raised to $16 from $15 at Craig-Hallum
TipRanks·03/06 12:35
Bioventus price target raised to $14 from $13 at Barrington
TipRanks·03/06 11:57
Canaccord Genuity Sticks to Its Buy Rating for Bioventus (BVS)
Simply Wall St·03/06 00:33
Bioventus (BVS) Profitability Pivot Challenges Skeptics Despite Slower Revenue Growth Forecasts
NASDAQ·03/05 21:16
Noteworthy Thursday Option Activity: ALK, BVS, UPS
Same Industry
Name/Symbol
Change%
Price